Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes
NCT01413204
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
272
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
TA-7284 Low
DRUG:
TA-7284 High
DRUG:
Placebo
Sponsor
Tanabe Pharma Corporation